Have you ever lay in bed tossing and turning, wishing you could fall asleep? While most people have trouble falling asleep some nights because of a late evening coffee or a stressful day, those who suffer from chronic insomnia are at a serious health risk if they don’t get an adequate amount of sleep. Approximately 15 percent of older adults in the United States suffer chronic insomnia, which can lead the way to cardiovascular disease, hypertension, weight gain, type 2 diabetes and even an earlier death.
Life science researchers at the University of California, Los Angeles have discovered the answer to two questions whose answers have eluded insomnia and sleep researchers in the past: Can treating insomnia reduce inflammation, and what is the most effective therapy for treating insomnia? The study, published in the journal Sleep¸ shows that treating insomnia led to decreases in a known marker of inflammation called C-reactive protein (CRP).
Read More
Tags:
University of California Los Angeles,
life science research,
insomnia
This June, we saw that Ann Arbor researchers were adjusting the process of cell autophagy in order to fight cancerous tumors. (You can read our article on the subject here.) This September, life scientists at the University of California, Los Angeles have found that tapping into autophagy may prevent the inevitable: that is, the aging of the human body.
Tags:
2014,
CA,
University of California Los Angeles,
California,
Los Angeles,
LAVS,
UCLA,
Biotechnology Vendor Showcase
Part of a new $37.5 million life science grant from the Defense Advanced Research Projects Agency has been made available to researchers at the University of California, Los Angeles. The research funding will be shared with fellow science researchers at the University of Pennsylvania to build and test wireless implantable devices that can detect memory deficits caused by injury and try to restore normal function. The purpose of these devices is to help improve brain function for service members, veterans and others after traumatic brain injury or disease.
Tags:
2014,
CA,
University of California Los Angeles,
new research funding,
California,
Los Angeles,
LAVS,
UCLA,
Biotechnology Vendor Showcase,
new research grant
A research scientist at the University of California, Los Angeles recently received a $5.1 million life science grant for stem cell research from the California Institute of Regenerative Medicine. California’s state stem cell agency awarded the new research funding to UCLA’s Dr. John Chute so that he may further his investigations into creating new stem cell therapies in the medical field.
Tags:
2014,
CA,
University of California Los Angeles,
new research funding,
California,
Los Angeles,
LAVS,
UCLA,
Biotechnology Vendor Showcase,
life science grant
Two UCLA Researchers recently received major multimillion dollar stem cell grants to help bring the benefits of new stem cell research to patients. These grants will fund two groundbreaking clinical trials set to begin in the beginning of 2014.
Tags:
2014,
University of California Los Angeles,
Stem cell research,
Southwest,
California,
Los Angeles,
LAVS,
BioResearch Product Faire Event,
UCLA,
new funding
UCLA researchers have developed an innovative approach to diagnosing cancer. This research has excellent commercial applications and is already in the process of being translated into a novel technology by a Los Angeles start up. The new technique allows researchers to very accurately diagnose cancers by observing the physical characteristics of cells in bodily fluids.
Tags:
2014,
University of California Los Angeles,
cancer research,
Southwest,
California,
Los Angeles,
Cytometry,
LAVS,
BioResearch Product Faire Event,
UCLA
University of California life science researchers at the Jonsson Comprehensive Cancer Center have recently developed a novel and innovative cancer therapy approach that uses nanotechnology to fight brain cancer. This new technology uses nanotechnology structures called “nanodiamonds” to deliver chemotherapy agents directly to the cancerous areas in brain cancer patients.
Tags:
2014,
CA,
University of California Los Angeles,
2013,
cancer research,
nanotechnology,
Southwest,
California,
Los Angeles,
LAVS,
UCLA,
Biotechnology Vendor Showcase
Reading our Science Market Update blog is a great way to stay informed of industry trends and research, funding and life science building news, but did you know that there is also a great deal of funding and life science market news available on our company news blog? We have put together a list, including links to the articles, of some recent news posted on our Life Science Company and Industry News Briefs blog available to life science sales and marketing professionals interested in staying informed of life science marketing and industry news.
Tags:
2014,
University of California Los Angeles,
Harvard University,
Rockefeller University,
University of Arizona,
University of Pittsburgh,
Pennsylvania,
Northeast,
University of Pennsylvania,
UPenn,
New York,
UPITT,
Southwest,
California,
Los Angeles,
Alabama,
University of Alabama,
Southern,
Massachusetts,
Life Science Company and Industry News Briefs,
Arizona,
Boston,
LAVS,
Philadelphia,
UAZ,
RockU,
BioResearch Product Faire Event,
UAlab,
Harvard,
Birmingham,
Front Line,
Tucson,
Pittsburgh,
Stony Brook,
industry news,
funding news,
Science Market Update,
Science Researcher Update,
NIH grants,
life science events,
SunySB
You might expect the barrage of brilliant lab-on-a-cell-phone inventions that come out of the Ozcan Nano/Bio Photonics Lab at the University of California Los Angeles to eventually dwindle, or perhaps only leave us moderately impressed after a while, but that's not the case. Less than three weeks into 2013, the Ozcan Research Group published on their development of a new optical microscopy platform which uses liquid nanolenses that self-assemble around tiny objects (in the sub–100-nanometer range), allowing it to detect viruses and nanoparticles. That paper was published online in the journal Nature Photonics and was the subject of a recent UCLA research news release. Also this month, the Royal Society of Chemistry published the paper Cost-effective and Rapid Blood Analysis on a Cell-phone. And the international society for optics and photonics, SPIE, announced a new annual award for 2013: the Biophotonics Technology Innovator Award. One guess who its first recipient is? Not a shabby way to start the new year at all.
Tags:
2014,
CA,
University of California Los Angeles,
2013,
Photonics,
Ozcan Nano/Bio Photonics Lab,
Microscopy,
Lab-on-a-chip Technology,
Southwest,
California,
University of California,
Los Angeles,
LAVS,
UCLA,
Biotechnology Vendor Showcase
In 2002, entertainment mogul David Geffen gave an unrestricted gift of $200M to the University of Calfornia Los Angeles' School of Medicine, which was subsequently named the David Geffen School of Medicine (DGSOM) in recognition of his generosity. Now, Mr. Geffen has made a further gift of $100M to establish a medical scholarship fund that will offer full funding to the most qualified and promising medical students, whether they are pursuing the MD degree or the MD/PhD in UCLA's renowned Medical Scientist Training Program. As the aim of the scholarship program is to recruit the best students in the world to DGSOM, both American and international students are eligible. All costs including living expenses and supplies are covered by the award and are offered for all 4 years (or 8 in the combined MD/PhD scientist program).
Tags:
CA,
University of California Los Angeles,
California,
2012,
Los Angeles,
Funding,
UCLA,
Biotechnology Vendor Showcase,
medical school,
charitable giving
